Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis-Reference-Cited by-同舟云学术

Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis

Published:2002-04 Issue:4 Volume:39 Page:695-705
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Hamano Kazumasa,Iwano Masayuki,Akai Yasuhiro,Sato Hiroaki,Kubo Atsushi,Nishitani Yoshiharu,Uyama Hideto,Yoshida Yukiko,Miyazaki Masanobu,Shiiki Hideo,Kohno Shigeru,Dohi Kazuhiro

Publisher

Elsevier BV

Subject

Nephrology

Reference55 articles.

1. Coagulation and renal disease;Kincaid-Smith;Kidney Int,1972

2. The pathogenetic role of the coagulation process in rabbit. Masugi nephritis;Vssali;Am J Pathol,1964

3. Primary glomerulonephritis;Nield,1989

4. Anticoagulants are of value in the treatment of renal disease;Kincaid-Smith;Am J Kidney Dis,1984

5. Long-term effect of urokinase therapy in IgA nephropathy;Miura;Clin Nephrol,1989

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Toll-like receptor 3 involvement in vascular function;European Journal of Pharmacology;2024-09

2. The correlation between anti-phospholipase A2 receptor antibodies and hypercoagulability in patients with idiopathic membranous nephropathy;Renal Failure;2024-07-08

3. Glucocorticoid- and pioglitazone-induced proteinuria reduction in experimental NS both correlate with glomerular ECM modulation;iScience;2024-01

4. Impact of Aging and Cellular Senescence in the Pathophysiology of Preeclampsia;Comprehensive Physiology;2023-09-28

5. Obesity and chronic kidney disease: A current review;Obesity Science & Practice;2022-07-19